Market Cap 8.26B
Revenue (ttm) 570.40M
Net Income (ttm) 223.19M
EPS (ttm) N/A
PE Ratio 34.21
Forward PE 38.91
Profit Margin 39.13%
Debt to Equity Ratio 0.00
Volume 3,097,300
Avg Vol 2,064,100
Day's Range N/A - N/A
Shares Out 188.27M
Stochastic %K 3%
Beta 1.38
Analysts Sell
Price Target $68.25

Company Profile

Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants...

Industry: Health Information Services
Sector: Healthcare
Phone: 650 549 4330
Address:
500 3rd Street, Suite 510, San Francisco, United States
Buckanator
Buckanator Dec. 12 at 1:11 PM
$DOCS You haven’t stolen my shares and never will because I know this will make me 50% eventually and I’m patient
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 11 at 11:39 PM
Actionable Trade Alert for $DOCS: Market Context: $DOCS is currently trading at $44.67, near its 60D low of $44.4, indicating potential support. The RSI at 44.12 suggests the stock is neither overbought nor oversold, providing room for upward movement. Directional Bias: The stock is below the 30-day MA of 52.49 and the 50-day MA of 59.01, indicating a bearish trend. However, being close to the low end of its 60-day range may present a buying opportunity as it could rebound. Trade Plan: - Suggested Entry: $45.00 - Stop Loss: $43.00 (1.79 ATR below entry) - Take Profit Targets: 1. $50.00 (11.1% ROI) 2. $55.00 (22.2% ROI) 3. $52.50 (17.5% ROI) With a clear risk-reward ratio, this plan allows for a potential 17%+ ROI on the third target. Monitor closely for market conditions and adjust as necessary. https://privateprofiteers.com
0 · Reply
StockHunter75
StockHunter75 Dec. 11 at 8:09 PM
$DOCS Way oversold, adding here.
0 · Reply
Buckanator
Buckanator Dec. 11 at 8:02 PM
$DOCS Five straight down days, talk about manipulation on a good highly profitable company.
0 · Reply
Buckanator
Buckanator Dec. 10 at 2:55 PM
$DOCS I’ve been quietly adding for the inevitable climb. Use the shorts manipulation to your advantage I say.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 3:42 AM
Actionable Trade Alert for $DOCS: Market Context: $DOCS is currently trading at $45.13, below its 30-day (MA30) and 50-day (MA50) moving averages, indicating bearish sentiment. The RSI at 43.09 suggests that the stock is nearing oversold conditions, which could lead to a potential reversal. Directional Bias: Given the RSI's proximity to oversold levels and the stock's recent low of $44.98, there is a possibility of a bounce back. However, the stock is still below both MAs, indicating caution. Trade Plan: - Suggested Entry: $45.50 (slightly above the last close to confirm upward momentum) - Stop Loss: $43.00 (to limit potential losses) - Take Profit Targets: 1. Target 1: $50.00 (10.5% gain) 2. Target 2: $55.00 (21.5% gain) 3. Target 3: $53.00 (17.5% gain) With a potential ROI of over 17% on Target 3, this trade offers a favorable risk-reward ratio. Monitor closely for any market changes. https://privateprofiteers.com
0 · Reply
Walkadon
Walkadon Dec. 9 at 9:07 PM
$DOCS Stock is sick...... upgrades, strong balance sheet, checks the boxes with a top tier valuation, but making new lows and lower highs....... no bounce happening, just a slow bleed on above average volume.
0 · Reply
JarvisFlow
JarvisFlow Dec. 9 at 3:39 PM
Barclays has adjusted their stance on Doximity ( $DOCS ), setting the rating to Overweight with a target price of 63.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 8 at 11:30 PM
Actionable Trade Alert for $DOCS: Market Context: $DOCS is currently trading at $46.24, with an RSI of 47.46 indicating a neutral momentum. The stock is below its 30-day moving average (MA30) of 54.74 and 50-day moving average (MA50) of 60.7, suggesting bearish pressure. However, the price is closer to the 60-day low of 45.29, indicating potential support. Directional Bias: The neutral RSI and proximity to the 60-day low suggest a possible reversal or consolidation. A breakout above the MA30 could signal a bullish trend. Trade Plan: - Suggested Entry: $46.50 - Stop Loss: $44.50 (risking $2.00) - Take Profit Targets: 1. $50.00 (7.5% ROI) 2. $54.00 (16.7% ROI) 3. $54.25 (17.3% ROI) Target 3 provides an ROI of over 17%, making this a compelling trade setup. Monitor for price action around the entry and adjust stop loss as necessary. https://privateprofiteers.com
0 · Reply
high_tech_texan
high_tech_texan Dec. 6 at 10:27 PM
$DOCS Looks oversold - thinking about dipping my toe in here Monday.
0 · Reply
Latest News on DOCS
Doximity, Inc. (DOCS) Q2 2026 Earnings Call Transcript

Nov 6, 2025, 8:56 PM EST - 5 weeks ago

Doximity, Inc. (DOCS) Q2 2026 Earnings Call Transcript


Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript

Aug 7, 2025, 9:50 PM EDT - 4 months ago

Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript


Doximity (DOCS) Q1 Revenue Rises 15%

Aug 7, 2025, 8:33 PM EDT - 4 months ago

Doximity (DOCS) Q1 Revenue Rises 15%


Doximity Acquires Pathway, a Leader in AI Clinical Reference

Aug 7, 2025, 4:02 PM EDT - 4 months ago

Doximity Acquires Pathway, a Leader in AI Clinical Reference


Doximity Announces Fiscal 2026 First Quarter Financial Results

Aug 7, 2025, 4:01 PM EDT - 4 months ago

Doximity Announces Fiscal 2026 First Quarter Financial Results


Doximity: Slowing Sales And EBITDA Growth

Jul 23, 2025, 3:35 PM EDT - 5 months ago

Doximity: Slowing Sales And EBITDA Growth


Doximity Crushes The Rule Of 40 - Try Rule Of 58

Jul 2, 2025, 10:36 AM EDT - 5 months ago

Doximity Crushes The Rule Of 40 - Try Rule Of 58


Doximity: A Closer Look at Its Investment Potential

May 20, 2025, 7:00 PM EDT - 7 months ago

Doximity: A Closer Look at Its Investment Potential


Doximity: Strong Growth but What's Next?

May 19, 2025, 9:04 AM EDT - 7 months ago

Doximity: Strong Growth but What's Next?


Doximity Stock 7.8% Higher After Key Trading Signal

May 19, 2025, 7:47 AM EDT - 7 months ago

Doximity Stock 7.8% Higher After Key Trading Signal


These Analysts Cut Their Forecasts On Doximity After Q4 Results

May 16, 2025, 1:51 PM EDT - 7 months ago

These Analysts Cut Their Forecasts On Doximity After Q4 Results


Why Doximity Stock Is Plummeting Today

May 16, 2025, 12:43 PM EDT - 7 months ago

Why Doximity Stock Is Plummeting Today


Doximity, Inc. (DOCS) Q4 2025 Earnings Call Transcript

May 15, 2025, 8:35 PM EDT - 7 months ago

Doximity, Inc. (DOCS) Q4 2025 Earnings Call Transcript


Doximity Stock Drops 20% After Outlook Disappoints

May 15, 2025, 5:55 PM EDT - 7 months ago

Doximity Stock Drops 20% After Outlook Disappoints


Doximity: Rating Downgrade As Near-Term Upside Is Priced In

Feb 14, 2025, 5:53 PM EST - 10 months ago

Doximity: Rating Downgrade As Near-Term Upside Is Priced In


Doximity Momentum, Big Money Support Stays Strong

Feb 14, 2025, 7:49 AM EST - 10 months ago

Doximity Momentum, Big Money Support Stays Strong


Doximity Q3 Earnings: Outpacing Even Management's Expectations

Feb 10, 2025, 12:04 PM EST - 10 months ago

Doximity Q3 Earnings: Outpacing Even Management's Expectations


Why Doximity Stock Skyrocketed Higher Today

Feb 7, 2025, 12:01 PM EST - 11 months ago

Why Doximity Stock Skyrocketed Higher Today


Doximity shares pop 30% on revenue beat, rosy guidance

Feb 7, 2025, 10:38 AM EST - 11 months ago

Doximity shares pop 30% on revenue beat, rosy guidance


Doximity, Inc. (DOCS) Q3 2025 Earnings Call Transcript

Feb 6, 2025, 8:01 PM EST - 11 months ago

Doximity, Inc. (DOCS) Q3 2025 Earnings Call Transcript


Doximity Surpasses EPS, Revenue Goals

Feb 6, 2025, 4:39 PM EST - 11 months ago

Doximity Surpasses EPS, Revenue Goals


Doximity Announces Fiscal 2025 Third Quarter Financial Results

Feb 6, 2025, 4:01 PM EST - 11 months ago

Doximity Announces Fiscal 2025 Third Quarter Financial Results


Buckanator
Buckanator Dec. 12 at 1:11 PM
$DOCS You haven’t stolen my shares and never will because I know this will make me 50% eventually and I’m patient
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 11 at 11:39 PM
Actionable Trade Alert for $DOCS: Market Context: $DOCS is currently trading at $44.67, near its 60D low of $44.4, indicating potential support. The RSI at 44.12 suggests the stock is neither overbought nor oversold, providing room for upward movement. Directional Bias: The stock is below the 30-day MA of 52.49 and the 50-day MA of 59.01, indicating a bearish trend. However, being close to the low end of its 60-day range may present a buying opportunity as it could rebound. Trade Plan: - Suggested Entry: $45.00 - Stop Loss: $43.00 (1.79 ATR below entry) - Take Profit Targets: 1. $50.00 (11.1% ROI) 2. $55.00 (22.2% ROI) 3. $52.50 (17.5% ROI) With a clear risk-reward ratio, this plan allows for a potential 17%+ ROI on the third target. Monitor closely for market conditions and adjust as necessary. https://privateprofiteers.com
0 · Reply
StockHunter75
StockHunter75 Dec. 11 at 8:09 PM
$DOCS Way oversold, adding here.
0 · Reply
Buckanator
Buckanator Dec. 11 at 8:02 PM
$DOCS Five straight down days, talk about manipulation on a good highly profitable company.
0 · Reply
Buckanator
Buckanator Dec. 10 at 2:55 PM
$DOCS I’ve been quietly adding for the inevitable climb. Use the shorts manipulation to your advantage I say.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 3:42 AM
Actionable Trade Alert for $DOCS: Market Context: $DOCS is currently trading at $45.13, below its 30-day (MA30) and 50-day (MA50) moving averages, indicating bearish sentiment. The RSI at 43.09 suggests that the stock is nearing oversold conditions, which could lead to a potential reversal. Directional Bias: Given the RSI's proximity to oversold levels and the stock's recent low of $44.98, there is a possibility of a bounce back. However, the stock is still below both MAs, indicating caution. Trade Plan: - Suggested Entry: $45.50 (slightly above the last close to confirm upward momentum) - Stop Loss: $43.00 (to limit potential losses) - Take Profit Targets: 1. Target 1: $50.00 (10.5% gain) 2. Target 2: $55.00 (21.5% gain) 3. Target 3: $53.00 (17.5% gain) With a potential ROI of over 17% on Target 3, this trade offers a favorable risk-reward ratio. Monitor closely for any market changes. https://privateprofiteers.com
0 · Reply
Walkadon
Walkadon Dec. 9 at 9:07 PM
$DOCS Stock is sick...... upgrades, strong balance sheet, checks the boxes with a top tier valuation, but making new lows and lower highs....... no bounce happening, just a slow bleed on above average volume.
0 · Reply
JarvisFlow
JarvisFlow Dec. 9 at 3:39 PM
Barclays has adjusted their stance on Doximity ( $DOCS ), setting the rating to Overweight with a target price of 63.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 8 at 11:30 PM
Actionable Trade Alert for $DOCS: Market Context: $DOCS is currently trading at $46.24, with an RSI of 47.46 indicating a neutral momentum. The stock is below its 30-day moving average (MA30) of 54.74 and 50-day moving average (MA50) of 60.7, suggesting bearish pressure. However, the price is closer to the 60-day low of 45.29, indicating potential support. Directional Bias: The neutral RSI and proximity to the 60-day low suggest a possible reversal or consolidation. A breakout above the MA30 could signal a bullish trend. Trade Plan: - Suggested Entry: $46.50 - Stop Loss: $44.50 (risking $2.00) - Take Profit Targets: 1. $50.00 (7.5% ROI) 2. $54.00 (16.7% ROI) 3. $54.25 (17.3% ROI) Target 3 provides an ROI of over 17%, making this a compelling trade setup. Monitor for price action around the entry and adjust stop loss as necessary. https://privateprofiteers.com
0 · Reply
high_tech_texan
high_tech_texan Dec. 6 at 10:27 PM
$DOCS Looks oversold - thinking about dipping my toe in here Monday.
0 · Reply
RunnerSignals
RunnerSignals Dec. 6 at 6:04 PM
$BRX $DOCS $MSI $SIG $SMA oversold alert! Contrarian traders take note these might bounce soon https://stocksrunner.com/news/2025-12-06-daily-market-pulse-insights-reveal-advanced-technical-trends
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 2:30 AM
Actionable Trade Alert for $DOCS: Market Context: $DOCS is currently trading at $51.31, showing a neutral to bullish sentiment given the RSI of 55.94, which indicates potential upward momentum. The stock is below its MA30 of 56.1 and significantly below its MA50 of 61.83, suggesting a recovery opportunity. Directional Bias: The current price is closer to the 60D low of 46.04 than the high of 76.51, indicating potential for an upward move. With the RSI nearing the mid-point, there’s room for growth before hitting overbought conditions. Trade Plan: - Suggested Entry: $51.31 - Stop Loss: $47.50 (approximately 7% below entry) - Take Profit Targets: 1. $56.00 (10% gain) 2. $60.00 (17% gain) 3. $60.00 (17% gain) The third target aligns with a substantial ROI, making this a strategic entry point for a bullish reversal. Monitor price action closely. https://privateprofiteers.com
0 · Reply
Arcides
Arcides Dec. 6 at 2:27 AM
$DOCS complete piece of shit, no news 3X+ average dump..
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 10:05 PM
Actionable Trade Alert for $DOCS: Market Context: $DOCS is currently trading at $51.31, showing a neutral to bullish sentiment given the RSI of 55.94, which indicates potential upward momentum. The stock is below its MA30 of 56.1 and significantly below its MA50 of 61.83, suggesting a recovery opportunity. Directional Bias: The current price is closer to the 60D low of 46.04 than the high of 76.51, indicating potential for an upward move. With the RSI nearing the mid-point, there’s room for growth before hitting overbought conditions. Trade Plan: - Suggested Entry: $51.31 - Stop Loss: $47.50 (approximately 7% below entry) - Take Profit Targets: 1. $56.00 (10% gain) 2. $60.00 (17% gain) 3. $60.00 (17% gain) The third target aligns with a substantial ROI, making this a strategic entry point for a bullish reversal. Monitor price action closely. https://privateprofiteers.com
0 · Reply
Walkadon
Walkadon Dec. 5 at 8:07 PM
$DOCS Buy after earnings and the lawsuits settle, and after the dust settles on whether big pharma will continue to buy ads at same scale, with the big shakeup in medical biz underway and the advent of Trump RX and others. Things are unclear right now, just like was warned in the recent earnings report.
0 · Reply
optioned
optioned Dec. 5 at 7:54 PM
$DOCS Doubling up here. This looks like someone exiting a large position, which obviously isn't a promising development. But in a stock with light volume the move lower is greatly exaggerated. Three month PT = bounce then fill the gap back up to $62
0 · Reply
StockHunter75
StockHunter75 Dec. 5 at 7:44 PM
$DOCS Calling bottom.
0 · Reply
StockHunter75
StockHunter75 Dec. 5 at 7:39 PM
$DOCS Time to buy.
2 · Reply
StockHunter75
StockHunter75 Dec. 5 at 7:25 PM
$DOCS Added a starter.
0 · Reply
_www_larval_com_
_www_larval_com_ Dec. 5 at 6:22 PM
Dufus here, $DOCS just reversed 3% higher to -6% (~2Mv) moments ago, 12/19 options, follow for more volatility.
0 · Reply
BullYa
BullYa Dec. 5 at 6:22 PM
$DOCS 📉 $45?
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 4 at 2:52 PM
$DOCS Current Stock Price: $51.20 Contracts to trade: $50 DOCS Dec 19 2025 Call Entry: $2.16 Exit: $2.98 ROI: 38% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply